In early 2026, the success of mRNA platforms in other disease areas is sparking a major push for a new generation of "ultra-stable" mRNA-based polio vaccines. These 2026 research projects aim to create a vaccine that does not require a strict cold chain and can be easily administered via microneedle patches rather than traditional needles and syringes. In early 2026, this "patch" technology is...